1 Min Read
* Says it received patent on Aug. 17, for fragment antigen binding specifically binding to epidermal growth factor receptor
* Patent number is 10-2015-0126894
Source text in Korean: goo.gl/suXxyL
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.